Literature DB >> 17971884

Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.

Patricia Lee1, David DiPersio, Rebecca N Jerome, Arthur P Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17971884      PMCID： PMC2000794          DOI： 10.3163/1536-5050.95.4.374

Source DB:  PubMed          Journal:  J Med Libr Assoc        ISSN： 1536-5050


× No keyword cloud information.
  22 in total

1.  Two new antibiotics; antibacterial activity of novobiocin and vancomycin.

Authors:  R W FAIRBROTHER; B L WILLIAMS
Journal:  Lancet       Date:  1956-12-08       Impact factor: 79.321

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

3.  In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.

Authors:  J A Washington; P E Hermans; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-07       Impact factor: 7.616

4.  Measuring pre- and post-dose vancomycin levels--time for a change?

Authors:  C Catchpole; J G Hastings
Journal:  J Med Microbiol       Date:  1995-05       Impact factor: 2.472

5.  Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.

Authors:  Meghan N Jeffres; Warren Isakow; Joshua A Doherty; Peggy S McKinnon; David J Ritchie; Scott T Micek; Marin H Kollef
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

Review 6.  The therapeutic monitoring of antimicrobial agents.

Authors:  E J Begg; M L Barclay; C J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

7.  Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.

Authors:  William Darko; Joseph J Medicis; Adrienne Smith; Roy Guharoy; David E Lehmann
Journal:  Pharmacotherapy       Date:  2003-05       Impact factor: 4.705

8.  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.

Authors:  M D Kitzis; F W Goldstein
Journal:  Clin Microbiol Infect       Date:  2006-01       Impact factor: 8.067
View more
  2 in total

Review 1.  Strategies for appropriate antibiotic use in intensive care unit.

Authors:  Camila Delfino Ribeiro da Silva; Moacyr Silva Júnior
Journal:  Einstein (Sao Paulo)       Date:  2015-06-30

2.  Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates.

Authors:  Christine Dieterich; Angela Puey; Sylvia Lin; Sylvia Lyn; Robert Swezey; Anna Furimsky; David Fairchild; Jon C Mirsalis; Hanna H Ng
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.